Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BCG, the only licensed vaccine against tuberculosis (TB), provides geographically variable protection, an effect ascribed to exposure to environmental mycobacteria (EM). Here we show that altering the intestinal microbiota of mice by early-life infection with the commensal bacterium Helicobacter hepaticus (Hh) increases their susceptibility to challenge with Mycobacterium tuberculosis (Mtb). Furthermore Hh-infected mice immunised parenterally with the recombinant subunit vaccine, human adenovirus type 5 expressing the immunodominant antigen 85A of Mtb (Ad85A), display a reduced lung immune response and protection against Mtb challenge is also reduced. Expression of interleukin 10 (IL10) messenger RNA is increased in the colon of Hh infected mice. Treatment of Hh-infected Ad85A-immunised mice with anti-IL10 receptor antibody, following challenge with Mtb, restores the protective effect of the vaccine. These data show for the first time that alteration of the intestinal microbiota by addition of a single commensal organism can profoundly influence protection induced by a TB subunit vaccine via an IL10-dependent mechanism, a result with implications for the deployment of such vaccines in the field.

Original publication

DOI

10.1016/j.vaccine.2015.02.041

Type

Journal article

Journal

Vaccine

Publication Date

08/04/2015

Volume

33

Pages

1808 - 1814

Keywords

Interleukin 10, Microbiota, Subunit vaccine, Tuberculosis, Adenoviruses, Human, Administration, Intranasal, Animals, Antigens, Bacterial, Bacterial Load, Colon, Gastrointestinal Microbiome, Helicobacter Infections, Helicobacter hepaticus, Humans, Interleukin-10, Lung, Mice, Mice, Inbred BALB C, Mycobacterium tuberculosis, Tuberculosis, Tuberculosis Vaccines, Vaccines, Subunit, Vaccines, Synthetic